Project Management. Dissemination and Exploitation Services in Horizon 2020

Transcription

1 Project Management Dissemination and Exploitation Services in Horizon 2020

2 Ontwerp: Studio Edwin de Boer 2

3 Project Management Dissemination and Exploitation Services in Horizon 2020

4 ttopstart - Project Management Our services ttopstart is a European science and business consulting company that specialises in leveraging the impact of your European project through providing professional management, dissemination and exploitation services. ttopstart focuses on projects in the field of life sciences, healthcare and medical technology. Professional Horizon 2020 Project Management Successful consortia have a sound scientific and non-scientific management framework. ttopstart provides professional non-scientific project management services as a full partner of your Horizon 2020 consortium. This allows you to focus on scientific management while ttopstart ensures that your project runs according to plan and fully in line with the EC grant agreement. We like to dedicate our time to the scientific activities within our Horizon 2020 project. General project management activities provided by ttopstart are therefore ideal for the performance of our Horizon 2020 consortium Dissemination and Exploitation services Horizon 2020 promises more breakthroughs and discoveries by taking great ideas from the lab to the market. Broad visibility and (preparing) strong implementation of your project's outcomes are therefore key requirements. ttopstart specialises in developing creative and detailed stakeholdertargeted plans for dissemination and exploitation of the proposed outcomes. Our experience with commercialisation translates directly into highly effective outreach to all relevant stakeholders. Our business strategy experience ensures that we can design a streamlined, lean route to market. The support of ttopstart in our Horizon 2020 project has enabled the start of a new venture to commercialise research tools and diagnostics 4

5 Project Management in Horizon 2020 ttopstart offers full non-scientific project management support as a partner of your Horizon 2020 consortium. Our goal is to facilitate a productive working atmosphere. Professional project management ttopstart has the unique skills and expertise to facilitate the productivity of your Horizon 2020 consortium. We remove the administrative burden associated with (international) projects, allowing you to focus on the work plan. We offer an extended package of project management services, including: Setting up the project management administration; Developing a cloud-based environment to share all project-related documents; Support with managing the budget; Coordination of annual project progress updates; Coordination of the activities for producing the deliverables, such as reports to the EC. Organising consortium meetings; Liaison with the EC; Monitoring the risk management plan. Our project management services are highly complementary to the activities of your consortium and can be customised in close collaboration with the professionals in your own organisation. 5

6 ttopstart - Project Management Project Management - application phase Our services are implemented through a dedicated Consortium Management Work Package, which will be part of your proposal. ttopstart offers the possibility to contribute to the design of this Work Package in the Application Phase. This ensures that your Horizon 2020 project gets an excellent score for the Implementation criterion. This will be based on the best practices we have gained in writing more than 100 EU projects. At project start, we will set up a virtual Project Management Office (PMO) specified to the needs of the project and consortium. Project Management project phase After the project has been granted, ttopstart will (co-)coordinate the Project Management Work Package and will fulfil the task of the PMO. The PMO will set up the material and guidelines to kickstart the project. During the project, the PMO will function as a helpdesk for the project partners. Questions regarding the non-scientific management of the project can be answered by the PMO. 6

7 Management Structure Steering committee PC, PM and vice-chair Representatives of participating institutions Project Management Office Management Team PC and PM WP Leaders Advisory Boards WP 1 WP 2 WP 3 WP 4 WP 5 Figure 1: An example of the position of the PMO co-coordinated by ttopstart 7

8 ttopstart - Project Management Dissemination and Exploitation ttopstart offers effective dissemination and exploitation activities to maximise the impact of your Horizon 2020 project. This will contribute to the overall success of the project, its visibility to relevant stakeholders and its promise to society. Dissemination Dissemination activities Dissemination activities should be carefully designed and well-timed, in order to maximise the visibility of your Horizon 2020 project to all relevant stakeholders. For example, a drug development consortium should disseminate the results to a range of stakeholders including the scientific community, the biotech/pharma industry, patients and society. This has a number of advantages, such as tapping into the enthusiasm and needs of patients, preparing market acceptance and paving the way for commercialisation. Each project has its own unique dissemination strategy. ttopstart can support you with developing a powerful dissemination strategy and will coordinate execution of the plan. How does it work? Application phase (optional) In the application phase, ttopstart can support you with the development of a dedicated Work Package on Dissemination and Exploitation in which the proposed activities are described. The communication and dissemination plan will consist of a detailed description of which communication and dissemination activities will be carried out, as well as how and when. The plan will be specified for each partner and per target audience, including for example (1) healthcare providers, (2) laboratory staff, (3) the scientific community, (4) bio-pharma industry, (5) public health agencies, (6) national governments, (7) patients and (8) the general public. For each stakeholder, the communication objectives, interaction and communication channels, and planning and execution will be worked out in a separate section. In particular, we will work out: Why do we want to communicate with particular stakeholders? What do we wish to communicate? What do we wish to learn from our stakeholders? When should we communicate? What are the best mechanisms for effective communication? What are challenges to effective communication? 8

9 Stakeholders Impact Strategy to maximise impact Patients Patients will benefit from a fast and accurate diagnosis. Inform patient organisations on increase in time and quality of diagnosis. Clinicians Clinicians will work with a preselected patient group which reduces workload and saves costs. Inform through high-impact publications and through KOLs of clinical added value. Diagnostic Laboratories The test can be commercialised by diagnostic laboratories in the near future. Inform through personal meetings. Health insurance companies Pharma, biotech, CROs Scientific community Health insurance companies will benefit from the diagnostic test since it saves healthcare costs. Early stratification will enable the selection of a highly suitable group of patients for a clinical trial. The diagnostic delivers novel knowledge on biomarkers and ther clinical utility. A cost-effectiveness study will be conducted to provide reliable evidence based for decision making. A dedicated industry day will be organised to explore potential partnerships. Through high-impact publications and presentations at conferences. Figure 2: Basic example of dissemination strategy and plans to reach stakeholders from a diagnostic project. Horizon 2020 project phase After the project has been granted, ttopstart will start to carry out the activities described in the dissemination plan. Different generic communication and dissemination tools will be developed including a project website, newsletters, a unique animation (see example here watch?v=tq980gevp0yz) of the project and social media channels. Furthermore, more targeted communication and dissemination tools will be developed and/or organised. These are designed to target a specific audience with a clear message. To take the example of drug development, an industry-day or dedicated workshop can be organised with companies and/or venture capitalists active in this field. The dissemination plans, tools and activities will be set up and managed by ttopstart as a partner (or as subcontractor for specific activities) within your Horizon 2020 project. These activities will fully comply with H2020 guidelines and EC regulations and will incorporate best practices from ongoing EU projects. 9

10 ttopstart - Project Management Exploitation ttopstart is experienced in science and business consulting. We make sure that market players become aware of project outcomes and interested in commercialisation. We have co-founded more than 20 biotech and medtech companies and were instrumental in initiating license agreements with industry, all resulting from EU-funded projects. Exploitation plans The impact of Horizon 2020 is more important than ever. Through broad experience in business development for the biotech/pharma and medtech industries, ttopstart has the network and skills to develop strong exploitation plans and ensure commercialisation of valuable project deliverables. Exploitation plans include a technology transfer strategy, an intellectual property policy, a market analysis and a detailed business plan. ttopstart also supports with a developing clear plans for non-commercial utilisation of valuable deliverables. We develop utilisation plans which can be targeted to different stakeholders such recommendations for policy makers or pave the way towards incorporation of the innovation into treatment guidelines. Market analysis and Business Case For deliverables that are valuable to society or industry, a thorough market analysis will be performed and a business case will be set up to assess the commercial potential. The market analysis will provide the foundation for defining the business strategy. It will consist of several optional components such as: (A) a top-down landscape analysis, including identification of business opportunities, competitive developments and IP potential, (B) a bottom-up market assessment where we identify potential customers and unmet stakeholder needs and (C) a customer examination for determining the interest for buying IP or products. These studies will show if there is a solid business case for commercialisation, including route-tomarket and knowledge protection strategy. This will pave the way for the next step in the commercialisation process: the development of a business plan. 10

11 1. Biomarker discovery 2. Marker validation 3. Assay development Data collection in EU wide Proof of concept SNP analysis Validated gene set genes Kit format High sens/spec 4. Clinical validation studies Retrospective and prospective clinical studies 5. Launch GMP manufacturing Update CE-IVD mark Post-market validation studies 6. Post-market activities Figure 3: Example of diagnostic development plan in a H2020 business plan Business plan development in Horizon 2020 projects If the business case is positive, a comprehensive business plan will be formulated. It will include a presentation of the product and concept, business and IP strategy, business model, partners, market size and dynamics, technical and operational planning, a SWOT analysis, and financial forecasts. The business plan will allow you to commercialise and finance your findings. ttopstart offers support for commercialisation. In the past, this has led to the launch and growth of 7 companies in different EU countries such as DualTpharma ( as a result from the FP7-METOXIA project ( 11

12 ttopstart - Project Management Market research Business strategy Financial planning Define oppertunity Identify unmet needs Identify key success criteria Competitive landscaping IP Landscaping Consult key opinion leaders Map Industrial needs Find strategic partners Etcetera Business model Route to market IP strategy Regulatory strategy Priduct development Corporate mission and vision Strategic partners Unique selling poits Action Plan Investment need Funding plan Revenue model Revenue planning Cash-flow prognosis Balance prognosis Profit & loss prognosis Risk & contingency plan Exit planning Market report Business plan Financial plan Figure 4: Business plan development process Follow-up funding after your Horizon 2020 project Successful Horizon 2020 projects generate innovative project deliverables. The large majority of these deliverables need further investigation and/or validation. The exploitation and utilisation plans form a good start for acquiring follow-up funding within Horizon 2020, including Marie Curie, ERC and Research and Innovation projects. If your Horizon 2020 project results in a new company, there are several different subsidies for Small Medium Enterprises (SMEs) that might propel the process, including Eurostars and the SME Instrument. 12

13 Why ttopstart? Our driver is the contribution to development of innovations that can strongly advance healthcare, such as diagnostics and treatments for a wide range of diseases. ttopstart combines science and business professionals in life sciences, medical technology and healthcare ttopstart has been built on the unique combination of science and business with a focus on the sectors life sciences, medical technology and healthcare. Our consultants have a solid scientific background combined with an extensive business skill set. This is a key advantage for your Horizon 2020 application considering the increased EC demands for translation of research, public private partnerships and societal impact. ttopstart consultants are involved in the set up and management of large European projects and have gained the necessary skills and best practices to support these large projects. ttopstart has ample business development expertise ttopstart consultants work for academic institutes, companies, governments, scientific societies, and patient organisations. We have gained the expertise and skill set to communicate with a broad range of different stakeholders. The dissemination and exploitation services are also highly synergised with our business development activities, which is essential for successful exploitation. ttopstart supports over 50 biotech and medtech spin-offs with business plan development, market studies and fund raising for innovative projects. We have developed business plans with unique biotech companies and large academic and medical institutes and European consortia that have resulted in financing rounds, licenses with industrial partners and more than 20 new start-up companies in the field different EU countries. ttopstart has gained experience in many EU projects ttopstart has acquired over 150 million funding for clients over the last 3 years. The experience includes numerous subsidies in life sciences and medical technology such as FP7/Horizon2020, European Research Council, Eurostars, NIH, Erasmus Mundus and IMI. ttopstart collaborates with dozens of universities, academic hospitals and companies in more than 10 European countries. 13

14 ttopstart - Project Management Contact us Jochem Bossenbroek MSc. - partner jochem@ttopstart.com Patrick de Boer MSc. - partner patrick@ttopstart.com Marije aan den Toorn, PhD - consultant marije@ttopstart.com ir Jasper Levink - partner jasper@ttopstart.com For more information please contact one of our consultants or visit our website at 14

15 15

16